TD Cowen lowered the firm’s price target on Agilon Health to $18 from $25 and keeps an Outperform rating on the shares. The firm said 3Q EBITDA was in line despite a material MA MLR miss that was offset by a material DCE MLR beat. MA margin outlook for 2H23 cut materially from rising costs DCE margin boosted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AGL: